# ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer

> **NCT00077246** · PHASE1,PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 64 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** paclitaxel albumin-stabilized nanoparticle formulation

## Key facts

- **NCT ID:** NCT00077246
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2008-10
- **Final completion:** —
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2013-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00077246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00077246, "ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00077246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*